COS EDI Webinar: November 23, 8PM ET
LGBTQ2S+ Issues in Ophthalmology: Working Towards Equity
Join us on Wednesday, November 23 as COS presents a webinar entitled LGBTQ2S+ Issues in Ophthalmology: Working Towards Equity, presented by Dr. Michael A. Puente.
In this 1.5-hour webinar, we will examine the status of health equity for LGBTQ2S+ patients and professional equity for LGBTQ2S+ ophthalmologists, with a view to creating safe spaces for and allyship with the LGBTQ2S+ community. A lecture by Dr. Michael Puente will be followed by a case-based panel discussion.
Date: Wednesday, November 23, 2022
Time: 8:00-9:30 pm ET
At the end of this webinar, participants will be able to:
Establish a baseline working knowledge of key concepts related to gender identity, gender expression, and sexual orientation
Examine the status of health equity for LGBTQ2S+ patients and professional equity for LGBTQ2S+ ophthalmologists
Create safe spaces for the LGBTQ2S+ community in both clinical and professional settings
Foster allyship with the LGBTQ2S+ community in ophthalmology
Dr. Michael A. Puente, Jr.
Michael Puente, MD, is an assistant professor of ophthalmology at the University of Colorado and a pediatric ophthalmologist at Children’s Hospital Colorado. He is a co-founder of the LGBTQ+ Interest Group of the American Academy of Ophthalmology (AAO) and volunteers as a mentor in AAO’s Minority Ophthalmology Mentoring Program. He serves as Vice-Chair of the Advocacy Committee of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) and is a member of the AAPOS Taskforce on Diversity, Equity, and Inclusion.
He has led an advocacy campaign to overturn the United States Food and Drug Administration’s ban on corneal donation by men who have sex with men, working with members of the United States Congress as well as leadership of the American Medical Association, Eye Bank Association of America, and AAO. He has presented on LGBTQ+ issues in ophthalmology at national and international conferences and has multiple publications in this field.
This webinar is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Ophthalmological Society. You may claim a maximum of 1.5 hours.
This webinar has been supported by an educational grant from Bayer.